Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 236  

    Article Cited by others


Implications of fluorodeoxyglucose uptake in low-intermediate grade metastatic neuroendocrine tumors from peptide receptor radionuclide therapy outcome viewpoint: A semi-quantitative standardized uptake value-based analysis

Adnan Aadil, Sampathirao Nikita, Basu Sandip

Year : 2019| Volume: 18| Issue : 4 | Page no: 389-395

   This article has been cited by
1 The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
Virginia Liberini,Martin W. Huellner,Serena Grimaldi,Monica Finessi,Philippe Thuillier,Alfredo Muni,Riccardo E. Pellerito,Mauro G. Papotti,Alessandro Piovesan,Emanuela Arvat,Désirée Deandreis
Diagnostics. 2020; 10(12): 1083
[Pubmed]  [Google Scholar] [DOI]
2 Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
Sandip Basu,Rahul V. Parghane,Rahul V. Kamaldeep,Sudipta Chakraborty
Seminars in Nuclear Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article